Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brian Dean

Showing results (171-180 of 248) with videos related to

Pageof 25
Sort By:
Journal of Affective Disorders|May 16, 2021
Abnormal gene expression of BDNF, but not BDNF-AS, in iPSC, neural stem cells and postmortem brain samples from bipolar disorderTamaki Ishima, Sebastian Illes, Yoshimi Iwayama, et al.
The International Journal of Neuropsychopharmacology|February 18, 2012
Widespread decreases in cortical muscarinic receptors in a subset of people with schizophreniaAndrew Stuart Gibbons, Elizabeth Scarr, Simone Boer, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|February 10, 2012
Validation and application of a liquid chromatography-tandem mass spectrometric method for the determination of G-856 (Cur-61414) in human plasma using semi-automated solid phase extractionYoung G Shin, Stan C Murakami, Michael H Buonarati, et al.
Aging Cell|February 28, 2009
Normal human aging and early-stage schizophrenia share common molecular profilesBin Tang, Wei-li Chang, Caroline M Lanigan, et al.
Frontiers in Cellular Neuroscience|June 28, 2013
Biomarker investigations related to pathophysiological pathways in schizophrenia and psychosisGursharan Chana, Chad A Bousman, Tammie T Money, et al.
The AAPS Journal|June 29, 2016
Recommendations on the Development of a Bioanalytical Assay for 4β-Hydroxycholesterol, an Emerging Endogenous Biomarker of CYP3A ActivityAnne-Françoise Aubry, Brian Dean, Ulf Diczfalusy, et al.
The Australian and New Zealand Journal of Psychiatry|May 28, 2015
Changes in cortical N-methyl-D-aspartate receptors and post-synaptic density protein 95 in schizophrenia, mood disorders and suicideBrian Dean, Andrew S Gibbons, Simone Boer, et al.
Biomedical Chromatography : BMC|November 3, 2023
Impact assessment of metabolite instability in the development and validation of LC-MS/MS bioanalytical assays for measurement of rosuvastatin in human plasma and urine samplesYuxiang Cui, Kevin Kowalski, Michael Van Parys, et al.
The International Journal of Neuropsychopharmacology|July 28, 2011
Nicotinamide-N-methyltransferase (NNMT) in schizophrenia: genetic association and decreased frontal cortex mRNA levelsAnna Bromberg, Elad Lerer, Madhara Udawela, et al.
Bioanalysis|September 9, 2011
Evaluation of homogenization techniques for the preparation of mouse tissue samples to support drug discoveryXiaorong Liang, Savita Ubhayakar, Bianca M Liederer, et al.
Pageof 25

Showing results (171-180 of 248) with videos related to

Sort By:
Pageof 25
Journal of Affective Disorders|May 16, 2021
Abnormal gene expression of BDNF, but not BDNF-AS, in iPSC, neural stem cells and postmortem brain samples from bipolar disorderTamaki Ishima, Sebastian Illes, Yoshimi Iwayama, et al.
The International Journal of Neuropsychopharmacology|February 18, 2012
Widespread decreases in cortical muscarinic receptors in a subset of people with schizophreniaAndrew Stuart Gibbons, Elizabeth Scarr, Simone Boer, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|February 10, 2012
Validation and application of a liquid chromatography-tandem mass spectrometric method for the determination of G-856 (Cur-61414) in human plasma using semi-automated solid phase extractionYoung G Shin, Stan C Murakami, Michael H Buonarati, et al.
Aging Cell|February 28, 2009
Normal human aging and early-stage schizophrenia share common molecular profilesBin Tang, Wei-li Chang, Caroline M Lanigan, et al.
Frontiers in Cellular Neuroscience|June 28, 2013
Biomarker investigations related to pathophysiological pathways in schizophrenia and psychosisGursharan Chana, Chad A Bousman, Tammie T Money, et al.
The AAPS Journal|June 29, 2016
Recommendations on the Development of a Bioanalytical Assay for 4β-Hydroxycholesterol, an Emerging Endogenous Biomarker of CYP3A ActivityAnne-Françoise Aubry, Brian Dean, Ulf Diczfalusy, et al.
The Australian and New Zealand Journal of Psychiatry|May 28, 2015
Changes in cortical N-methyl-D-aspartate receptors and post-synaptic density protein 95 in schizophrenia, mood disorders and suicideBrian Dean, Andrew S Gibbons, Simone Boer, et al.
Biomedical Chromatography : BMC|November 3, 2023
Impact assessment of metabolite instability in the development and validation of LC-MS/MS bioanalytical assays for measurement of rosuvastatin in human plasma and urine samplesYuxiang Cui, Kevin Kowalski, Michael Van Parys, et al.
The International Journal of Neuropsychopharmacology|July 28, 2011
Nicotinamide-N-methyltransferase (NNMT) in schizophrenia: genetic association and decreased frontal cortex mRNA levelsAnna Bromberg, Elad Lerer, Madhara Udawela, et al.
Bioanalysis|September 9, 2011
Evaluation of homogenization techniques for the preparation of mouse tissue samples to support drug discoveryXiaorong Liang, Savita Ubhayakar, Bianca M Liederer, et al.
Pageof 25